-
-
-
-
-
-
-
Bernstein SocGen Group Upgrades Takeda Pharmaceutical (4502:JP) (TAK) to Outperform
-
-
-
-
-
-
-
Morgan Stanley Resumes Takeda Pharmaceutical (4502:JP) (TAK) at Overweight, 'Our second most preferred stock'
-
-
-
-
-
-
-
Takeda partners with VELA for wind-powered pharmaceutical shipping
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Takeda Pharmaceutical (TAK) Ahead of 'Key Upcoming Readouts'
-
-
-
-
-
-
-
Takeda (TAK) Receives EU Approval for ADZYNMA
-
-
-
-
-
483,873 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


